INDAPAMIDE WATSON indapamide hemihydrate 2.5mg sugar coated tablet blister pack

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

indapamide hemihydrate, Quantity: 2.5 mg

Disponible desde:

Medis Pharma Pty Ltd

Designación común internacional (DCI):

indapamide hemihydrate

formulario farmacéutico:

Tablet, sugar coated

Composición:

Excipient Ingredients: lactose monohydrate; maize starch; magnesium stearate; povidone; purified talc; calcium carbonate; titanium dioxide; sucrose; Acacia; ethyl acetate; purified water; stearic acid; industrial methylated spirit; polyvinyl acetate phthalate; Shellac; white beeswax; Carnauba Wax

Vía de administración:

Oral

Unidades en paquete:

60 tablets, 90 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Management of essential hypertension. It may be tried as the sole therapeutic agent in the treatment of mild to moderate hypertension. Normally indapamide is used as the initial agent in multiple drug regimens.

Resumen del producto:

Visual Identification: White, biconvex, sugar coated tablets.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Estado de Autorización:

Licence status A

Fecha de autorización:

2012-04-05